WO2026003808 - SOLID STATE FORM OF ADAGRASIB AND PROCESS FOR PREPARATION

National phase entry is expected:
Publication Number WO/2026/003808
Publication Date 02.01.2026
International Application No. PCT/IB2025/056578
International Filing Date 27.06.2025
Title **
[English] SOLID STATE FORM OF ADAGRASIB AND PROCESS FOR PREPARATION
[French] FORME À L'ÉTAT SOLIDE D'ADAGRASIB ET PROCÉDÉ DE PRÉPARATION
Applicants **
ASSIA CHEMICAL INDUSTRIES LTD.
Inventors
MUTHUSAMY, Anantha Rajmohan
SOMASUNDARAM, Meenakshi Sundaram
KAUSHIK, Babita
RENGARAJ, Prathap
Priority Data
202411049781   28.06.2024   IN
202411053465   12.07.2024   IN
202411064687   27.08.2024   IN
Application details
Total Number of Claims/PCT *
Number of Independent Claims *
Number of Priorities *
Number of Multi-Dependent Claims *
Number of Drawings *
Pages for Publication *
Number of Pages with Drawings *
Pages of Specification *
*
Number of Office Actions *
*
International Searching Authority
*
Recordal of a Change of the Applicant's Name/Address
*
Type of Assignment
*
Applicant's Legal Status
*
*
*
*
*
*
Entry into National Phase under
*
Patent Delivery
*
Translation

* The data is based on automatic recognition. Please verify and amend if necessary.

** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.

Quotation for National Phase entry

Country StagesTotal
China Filing, Examination, Granting2827
EPO Filing, Examination, Granting18706
Japan Filing, Examination, Granting2769
South Korea Filing, Examination, Granting3394
USA Filing, Examination, Granting11340
MasterCard Visa
Total: 39,036
Contact Us
Abstract[English] The present disclosure relates to Adagrasib solid state forms and to Adagrasib trifluoroacetic acid salt and solid state form. In embodiments crystalline polymorphs of Adagrasib and of Adagrasib trifluoroacetic acid salt, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.[French] La présente divulgation concerne des formes à l'état solide d'adagrasib et un sel d'acide trifluoroacétique d'adagrasib et une forme à l'état solide. Des modes de réalisation de la présente divulgation concernent des polymorphes cristallins d'adagrasib et de sel d'acide trifluoroacétique d'adagrasib, des procédés de préparation de ceux-ci, des compositions pharmaceutiques de ceux-ci, et leurs procédés d'utilisation.

Rejoining the server...